Literature DB >> 2502380

Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells.

R Kremer1, I Bolivar, D Goltzman, G N Hendy.   

Abstract

Exposure of quiescent bovine parathyroid cells to serum or a serum substitute caused an elevation in [3H] thymidine incorporation, followed by an increase in cell number. This was preceded by a rapid transient rise in c-myc and c-fos proto-oncogene mRNA levels. Alterations in the medium calcium concentration had no effect on the growth state of quiescent parathyroid cells. In addition, varying the medium calcium concentration did not influence either the time course or the degree of induction of proto-oncogene expression or the subsequent increase in [3H] thymidine uptake or proliferation of stimulated parathyroid cells. In contrast, when 1,25-dihydroxycholecalciferol was added with serum or serum substitute to quiescent parathyroid cells, no increase in c-myc mRNA levels was observed, and the expected increase in parathyroid cell number failed to occur. The augmentation in c-fos mRNA in response to serum was not, however, altered by 1,25-dihydroxycholecalciferol. These results indicate that 1,25-dihydroxyvitamin D, but not extracellular calcium, may directly modulate parathyroid cell proliferation by altering the expression of specific replication-associated oncogenes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502380     DOI: 10.1210/endo-125-2-935

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  20 in total

Review 1.  Renal osteodystrophy.

Authors:  E A González; K J Martin
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  Comparison of active vitamin D compounds and a calcimimetic in mineral homeostasis.

Authors:  Loan Nguyen-Yamamoto; Isabel Bolivar; Stephen A Strugnell; David Goltzman
Journal:  J Am Soc Nephrol       Date:  2010-07-22       Impact factor: 10.121

3.  The mRNA expression of the human 1,25-dihydroxyvitamin D3 receptor and the c-myc protooncogene in cultured human keratinocytes.

Authors:  N M Hanafin; K S Persons; M F Holick
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-03       Impact factor: 2.416

Review 4.  Vitamin D and its analogs in chronic renal failure.

Authors:  E Slatopolsky; A J Brown
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 5.  The dynamic skeleton.

Authors:  Anda Gonciulea; Suzanne Jan de Beur
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

Review 6.  Minimizing bone abnormalities in children with renal failure.

Authors:  Helena Ziólkowska
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 7.  Regulation of parathyroid function in chronic renal failure.

Authors:  Mariano Rodriguez; Sagrario Cañadillas; Ignacio Lopez; Escolástico Aguilera-Tejero; Yolanda Almaden
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

8.  The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene.

Authors:  Ling Lin; Jian-Hua Zhang; Leelamma M Panicker; William F Simonds
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-05       Impact factor: 11.205

9.  Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

Authors:  N Fukuda; H Tanaka; Y Tominaga; M Fukagawa; K Kurokawa; Y Seino
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

Review 10.  Hyperparathyroidism and malnutrition with severe vitamin D deficiency.

Authors:  Amit Agarwal; Sushil Kumar Gupta; Ranjith Sukumar
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.